Suzy Jones
Follow
Get notifications in MyBN when activity occurs.
Suzy Jones
Non-Executive Director / Patrys
Suzy Jones has very extensive networks within the pharmaceutical and biotech companies and VC community in North America.
She is the founder and managing partner of DNA Ink LLC, a life sciences advisory and business development firm with clients in the United States, Germany, Israel and France. DNA Ink provides corporate strategic guidance to its clients that support corporate growth. Prior to starting her own firm, Ms Jones spent 20 years at Genentech where she served in many roles including as interim head of partnering, head of business development, senior project manager, and research associate. She managed several product teams including Rituxan, the first monoclonal antibody launched to treat cancer.
She is the founder and managing partner of DNA Ink LLC, a life sciences advisory and business development firm with clients in the United States, Germany, Israel and France. DNA Ink provides corporate strategic guidance to its clients that support corporate growth. Prior to starting her own firm, Ms Jones spent 20 years at Genentech where she served in many roles including as interim head of partnering, head of business development, senior project manager, and research associate. She managed several product teams including Rituxan, the first monoclonal antibody launched to treat cancer.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1506th | Patrys | -50% | -26% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Patrys | $1.3m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Patrys | 03 Nov 2020 |
